NASDAQ:OMCL Omnicell (OMCL) Stock Price, News & Analysis $35.03 +0.08 (+0.23%) Closing price 11/13/2026 04:00 PM EasternExtended Trading$36.04 +1.01 (+2.88%) As of 11/13/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Omnicell Stock (NASDAQ:OMCL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Omnicell alerts:Sign Up Key Stats Today's Range$34.59▼$35.1950-Day Range$32.23▼$39.4152-Week Range$31.75▼$55.00Volume313,243 shsAverage Volume627,007 shsMarket Capitalization$1.61 billionP/E Ratio36.49Dividend YieldN/APrice Target$57.86Consensus RatingModerate Buy Company Overview Omnicell, Inc. develops medication-management solutions for healthcare providers. Its products and services are designed to help manage medication storage, dispensing, inventory and workflows across healthcare settings. The company offers automated dispensing cabinets for patient-care areas, automation systems for central pharmacies, and software and analytics that support medication management. Its solutions serve hospitals, health systems, pharmacies and other care providers, including long-term and post-acute care organizations. Founded in 1992, Omnicell serves customers in the United States and internationally. Its offerings combine hardware, software and services intended to support medication availability, operational efficiency and patient safety.AI Generated. May Contain Errors. Read More Omnicell Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks65th Percentile Overall ScoreOMCL MarketRank™: 3.246224556795 of 5 starsOmnicell scored higher than 65% of companies evaluated by MarketBeat, and ranked 313th out of 893 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.3 / 5Analyst RatingModerate Buy Consensus RatingOmnicell has received a consensus rating of Moderate Buy. The company's average rating score is 2.90, and is based on 1 strong buy rating, 7 buy ratings, 2 hold ratings, and no sell ratings.Upside PotentialOmnicell has a consensus price target of $57.86, representing about 65.2% upside from its current price of $35.03.Amount of Analyst CoverageOmnicell has only been the subject of 4 research reports in the past 90 days.Read more about Omnicell's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth-25.61% Earnings GrowthEarnings for Omnicell are expected to decrease by -25.61% in the coming year, from $1.64 to $1.22 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Omnicell is 36.49, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.40.Price to Earnings Ratio vs. SectorThe P/E ratio of Omnicell is 36.49, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.56.Price to Earnings Growth RatioOmnicell has a PEG Ratio of 0.87. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioOmnicell has a P/B Ratio of 1.22. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.45% of the float of Omnicell has been sold short.Short Interest Ratio / Days to CoverOmnicell has a short interest ratio ("days to cover") of 6.34.Change versus previous monthShort interest in Omnicell has recently increased by 15.56%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldOmnicell does not currently pay a dividend.Dividend GrowthOmnicell does not have a long track record of dividend growth. News and Social Media3.1 / 5News Sentiment0.98 News SentimentOmnicell has a news sentiment score of 0.98. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.60 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Omnicell this week, compared to 4 articles on an average week.Search InterestOnly 1 people have searched for OMCL on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows8 people have added Omnicell to their MarketBeat watchlist in the last 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Omnicell insiders have not sold or bought any company stock.Percentage Held by Insiders2.92% of the stock of Omnicell is held by insiders.Percentage Held by Institutions97.70% of the stock of Omnicell is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Omnicell's insider trading history. Receive OMCL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Omnicell and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OMCL Stock News HeadlinesWhy Omnicell (OMCL) is a top momentum stock for the long termNovember 9, 2026 | msn.comLearn Why The Bull Case For Omnicell (OMCL) Could Change Following Raised Revenue GuidanceNovember 7, 2026 | finance.yahoo.comA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Without its chip, his AI satellites don't fly. Now he wants 1,000,000 of them in orbit, 100 times what's up there today, and every one pays this company a royalty. Dylan believes shares could react by December 8th.November 15 at 1:00 AM | Behind the Markets (Ad)Omnicell (NASDAQ:OMCL) Stock Dropped to "Buy" by Wall Street ZenNovember 7, 2026 | americanbankingnews.comOmnicell, Inc. (NASDAQ:OMCL) Stock Has Consensus Target Price of $57.86 According to AnalystsNovember 4, 2026 | americanbankingnews.comHead to Head Review: Omnicell (OMCL) & Its RivalsNovember 4, 2026 | americanbankingnews.comWhy Omnicell (OMCL) is a top value stock for the long termNovember 3, 2026 | msn.comOMCL Q3 deep dive: disciplined cost control offsets flat sales, software transition in early inningsNovember 3, 2026 | finance.yahoo.comSee More Headlines OMCL Stock Analysis - Frequently Asked Questions How have OMCL shares performed this year? Omnicell's stock was trading at $45.30 at the beginning of 2026. Since then, OMCL shares have decreased by 22.7% and is now trading at $35.03. How were Omnicell's earnings last quarter? Omnicell, Inc. (NASDAQ:OMCL) released its quarterly earnings results on Thursday, October, 29th. The company reported $0.58 EPS for the quarter, beating analysts' consensus estimates of $0.42 by $0.16. The firm's revenue for the quarter was down .9% compared to the same quarter last year. Read the conference call transcript. Does Omnicell have any subsidiaries? Omnicell subsidiaries include these companies: MarkeTouch Media LLC, ReCept Pharmacy, FDS Amplicare, 340B Link Business, InPharmics, Ateb Inc., Aesynt, and more. Who are Omnicell's major shareholders? Omnicell's top institutional shareholders include State Street Corp (4.55%), Boston Partners (1.17%), Fort Washington Investment Advisors Inc. OH (1.01%) and Public Sector Pension Investment Board (0.53%). Insiders that own company stock include Nnamdi Njoku, Corey J Manley and Mark W Parrish. View institutional ownership trends. How do I buy shares of Omnicell? Shares of OMCL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Omnicell own? Based on aggregate information from My MarketBeat watchlists, some other companies that Omnicell investors own include NVIDIA (NVDA), Micron Technology (MU), Johnson & Johnson (jnj), Merck & Co., Inc. (MRK), Advanced Micro Devices (AMD), PayPal (PYPL) and Bank of America (BAC). Company Calendar Last Earnings10/29/2026Today11/15/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1w+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 For the last 9 days, OMCL's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:OMCL CIK926326 Webwww.omnicell.com Phone(877) 415-9990Fax847-596-3402Employees3,580Year Founded1992Price Target and Rating Average Price Target for Omnicell$57.86 High Price Target$70.00 Low Price Target$45.00 Potential Upside/Downside+65.2%Consensus RatingModerate Buy Rating Score (0-4)2.90 Research Coverage10 Analysts Profitability EPS (Trailing Twelve Months)$0.96 Trailing P/E Ratio36.49 Forward P/E Ratio28.71 P/E Growth0.87Net Income$2.05 million Net Margins3.59% Pretax Margin5.41% Return on Equity5.69% Return on Assets3.61% Debt Debt-to-Equity Ratio0.13 Current Ratio1.65 Quick Ratio1.45 Sales & Book Value Annual Sales$1.18 billion Price / Sales1.36 Cash Flow$2.77 per share Price / Cash Flow12.64 Book Value$28.64 per share Price / Book1.22Miscellaneous Outstanding Shares45,990,000Free Float44,652,000Market Cap$1.61 billion OptionableOptionable Beta0.88 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:OMCL) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredUnbelievable…Congress is About to Do What?Jim Rickards, former advisor to the CIA, the Pentagon and the White House, says a key turning point in Washing...Paradigm Press | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omnicell, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omnicell With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.